Previsioni di mercato delle tecnologie PCR per Medio Oriente e Africa fino al 2030 - Analisi regionale - per tecnologia (PCR in tempo reale, PCR convenzionale, PCR con trascrizione inversa, PCR digitale, PCR Multiplex RT, PCR Hot Start e altre), offerte (reagenti e materiali di consumo, strumenti, software e servizi), applicazioni (analisi dell\'espressione genica, sequenziamento genetico, genotipizzazione, sintesi di acidi nucleici, convalida standard, diagnostica al punto di cura, applicazioni ambientali e altro) e utente finale (ospedali e centri diagnostici, mondo accademico e ricerca istituti, aziende farmaceutiche e biotecnologiche e altri)
Prevalenza in aumento delle malattie genetiche e infettive rafforza il mercato delle tecnologie PCR in Medio Oriente e Africa
Secondo le informazioni dell\'Organizzazione nazionale sulle condizioni genetiche o disabilità congenite, le malattie genetiche sono condizioni rare, ma complessivamente comprendono oltre 15.500 diagnosi positive ogni anno. Le stime pubblicate in un rapporto di MJH Life Sciences (USA) nel 2022 affermano che circa 300.000 neonati nascono con anemia falciforme (drepanocitosi) ogni anno a livello globale, pari al 5% della popolazione mondiale. Inoltre, secondo il rapporto di giugno 2020 di Novartis AG, la MCI colpisce circa otto milioni di persone in tutto il mondo. Circa 500 bambini muoiono ogni giorno per complicazioni legate alla morte improvvisa in Africa, dove la malattia ha il peso più elevato. Come risultato della crescente incidenza di MCI, l\'adozione della reazione a catena della polimerasi digitale (dPCR) è in aumento nei centri di patologia, in cui questa tecnologia viene sfruttata per prendere di mira varie sequenze specifiche del DNA per confermare diagnosi e progettare vari test clinici. La dPCR può colpire specifiche sequenze di DNA in una sola molecola di DNA. Questo strumento consente ai ricercatori di rilevare mutazioni genetiche rare difficili da identificare utilizzando la PCR in tempo reale. L’epidemia di COVID-19 ha avuto un impatto significativo sul mercato delle tecnologie PCR. La PCR è una tecnologia quasi onnipresente, robusta e affidabile utilizzata nella maggior parte dei laboratori di biologia molecolare per amplificare tratti specifici di DNA per la genotipizzazione, la clonazione e l\'analisi delle variazioni di singoli nucleotidi. Il DNA amplificato funge anche da base per la maggior parte delle preparazioni di sequenziamento di prossima generazione (NGS). Quasi tutti i test diagnostici hanno utilizzato la PCR in tempo reale per testare le persone che presentavano sintomi di COVID-19. La maggior parte delle aziende biotecnologiche e farmaceutiche ha spostato la propria attenzione verso le divisioni di ricerca e sviluppo (R&S) per trovare nuovi composti o approcci terapeutici per COVID-19, il che, a sua volta, ha avvantaggiato il mercato delle tecnologie PCR. Nel febbraio 2022, Roche ha aggiunto il sistema Cobas 5800, uno strumento di laboratorio molecolare appena rilasciato, al suo portafoglio PCR per il COVID-19 per l\'utilizzo nelle nazioni che accettano la certificazione CE. Questi prodotti includono i test Cobas SARS-CoV-2 e per l’influenza A/B, nonché il test qualitativo Cobas SARS-CoV-2. Il prodotto offre prestazioni ed efficienza uniformi nei test di laboratorio molecolari a basso, medio e alto volume. Pertanto, la crescente incidenza di malattie genetiche e infettive sostiene la crescita del mercato delle tecnologie PCR.
Panoramica del mercato delle tecnologie PCR in Medio Oriente e Africa
Il mercato delle tecnologie PCR in Medio Oriente e Africa è segmentato in Arabia Saudita, Emirati Arabi Uniti, Sud Africa e resto del Medio Oriente e dell\'Africa. Si prevede che la regione sperimenterà una crescita significativa dovuta a un aumento dello sviluppo di vari sistemi di reagenti e sistemi automatizzati in questa regione, a un\'ampia gamma di nuovi prodotti nei laboratori diagnostici e a un numero crescente di conferenze, incontri, workshop e simposi. L’Arabia Saudita è tra i paesi in più rapida crescita nel Medio Oriente e in Africa. Il cambiamento delle infrastrutture sanitarie attraverso partenariati pubblico-privato tra governo e attori internazionali rafforza il settore sanitario del Paese. Queste partnership e gli sforzi di privatizzazione sono in linea con le politiche “Vision 2030” del governo saudita per trasformare l’economia nazionale. Secondo l\'Amministrazione del commercio internazionale, il governo dell\'Arabia Saudita ha investito circa 65 miliardi di dollari per costruire le infrastrutture sanitarie del paese nell\'ambito della Vision 2030. Si prevede che maggiori investimenti in infrastrutture e innovazione favoriranno positivamente il mercato. Le tecnologie PCR hanno ampie applicazioni nella diagnosi di malattie infettive, oncologia, malattie autoimmuni, malattie genetiche, HIV/AIDS e altre. Viene utilizzato dai medici negli ospedali, nei laboratori e in altre strutture sanitarie e in varie fasi del processo di trattamento del paziente. Inoltre, gli studi sul polimorfismo del DNA, sul cancro del polmone e sul cancro del colon-retto utilizzano tecniche dPCR e qPCR per valutare l’espressione dell’mRNA dei geni, stimolando il mercato delle tecnologie PCR. L’Arabia Saudita ha un numero crescente di malattie genetiche dovute al matrimonio tra consanguinei e, quindi, l’aumento dello screening genetico prematrimoniale guida la crescita del mercato. Il governo dell’Arabia Saudita ha reso obbligatorio sottoporsi allo screening genetico prematrimoniale prima del matrimonio per verificare la compatibilità genetica e ridurre le malattie ereditarie del sangue come l’anemia falciforme e la beta-talassemia, che sono le più diffuse nel Paese. Pertanto, la crescente prevalenza di malattie genetiche e l’aumento dei test genetici prematrimoniali in Arabia Saudita guidano la crescita del mercato. Inoltre, il crescente numero di casi di cancro ha alimentato la ricerca sul cancro in Arabia Saudita. Secondo i dati Globocan 2020, il Paese ha registrato circa 27.885 nuovi casi di cancro. Il tasso di prevalenza a cinque anni del cancro in tutte le età è risultato pari a 237,4 per 100.000 persone, il che, a sua volta, spinge la domanda di tecnologie PCR in Arabia Saudita.
Entrate e previsioni del mercato delle tecnologie PCR per Medio Oriente e Africa fino al 2030 (milioni di dollari)
Segmentazione del mercato delle tecnologie PCR per Medio Oriente e Africa
Tecnologie PCR per Medio Oriente e Africa il mercato è segmentato in tecnologia, offerte, applicazione, utente finale e paese.
In base alla tecnologia, il mercato delle tecnologie PCR in Medio Oriente e Africa è segmentato in PCR in tempo reale, PCR convenzionale, trascrizione inversa, PCR digitale, RTPCR multiplex, PCR hot start e altri. Il segmento PCR in tempo reale deteneva la quota maggiore del mercato delle tecnologie PCR in Medio Oriente e Africa nel 2022.
In termini di offerte, il mercato delle tecnologie PCR in Medio Oriente e Africa è segmentato in reagenti e materiali di consumo, strumenti e software & Servizi. Il segmento dei reagenti e dei materiali di consumo deteneva la quota maggiore del mercato delle tecnologie PCR in Medio Oriente e Africa nel 2022. Inoltre, il segmento dei reagenti e dei materiali di consumo è classificato in reagenti, dimensioni delle fiale e altri materiali di consumo. Inoltre, la dimensione delle fiale è segmentata in 0,2 ml a 2 ml, 0,1 ml a 0,3 ml, 2 ml a 5 ml e altre fiale. Inoltre, il segmento degli strumenti è suddiviso in PCR da banco e termociclatori/PCR portatili.
In base all\'applicazione, il mercato delle tecnologie PCR in Medio Oriente e Africa è segmentato in analisi dell\'espressione genica, sequenziamento genetico, genotipizzazione, sintesi di acidi nucleici, convalida standard, applicazione diagnostica presso il punto di cura, applicazione ambientale e altro. Il segmento dell\'analisi dell\'espressione genica ha detenuto la quota maggiore del mercato delle tecnologie PCR in Medio Oriente e Africa nel 2022.
In base all\'utente finale, il mercato delle tecnologie PCR in Medio Oriente e Africa è segmentato in ospedali e centri diagnostici, farmaceutici e biotecnologie aziende, istituti accademici e laboratori di ricerca e altri. Il segmento degli ospedali e dei centri diagnostici deteneva la quota maggiore del mercato delle tecnologie PCR in Medio Oriente e Africa nel 2022.
Per paese, il mercato delle tecnologie PCR in Medio Oriente e Africa è stato classificato in Arabia Saudita, Sud Africa, Emirati Arabi Uniti e il resto del Medio Oriente e dell\'Africa. L\'Arabia Saudita ha dominato il mercato delle tecnologie PCR in Medio Oriente e Africa nel 2022.
Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co , Takara Bio Inc, Standard Bio Tools Inc ed Ellume Ltd sono alcune delle aziende leader che operano nel mercato delle tecnologie PCR in Medio Oriente e Africa.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa PCR Technologies Market - Key Industry Dynamics
4.1 PCR Technologies Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Rising Prevalence of Genetic and Infectious Diseases
4.3 Market Restraints
4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
4.4 Market Opportunities
4.4.1 Increasing Adoption of PCR Techniques in Emerging Countries
4.4.2 Increasing Demand for POC Testing
4.5 Future Trends
4.5.1 Advancements in PCR Technologies
4.6 Impact of Drivers and Restraints:
5. PCR Technologies Market - Middle East & Africa Market Analysis
5.1 PCR Technologies Market Revenue (US$ Million), 2020 - 2030
6. Middle East & Africa PCR Technologies Market Analysis - By Technology
6.1 Overview
6.2 Real Time PCR
6.2.1 Overview
6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Conventional PCR
6.3.1 Overview
6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Reverse Transcription PCR
6.4.1 Overview
6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.5 Digital PCR
6.5.1 Overview
6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.6 Multiplex RT PCR
6.6.1 Overview
6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.7 Hot Start PCR
6.7.1 Overview
6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.8 Others
6.8.1 Overview
6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa PCR Technologies Market Analysis - By Offerings
7.1 Overview
7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
7.3 Reagents and Consumables
7.3.1 Overview
7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
7.3.2.1.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
7.5 Software and Services
7.5.1 Overview
7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa PCR Technologies Market Analysis - By Application
8.1 Overview
8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Gene Expression Analysis
8.3.1 Overview
8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Genetic Sequencing
8.4.1 Overview
8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
8.5 Genotyping
8.5.1 Overview
8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
8.6 Nucleic Acid Synthesis
8.6.1 Overview
8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
8.7 Standard Validation
8.7.1 Overview
8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
8.8 Point of Care Diagnostics
8.8.1 Overview
8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
8.9 Environmental Application
8.9.1 Overview
8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
8.10 Others
8.10.1 Overview
8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa PCR Technologies Market Analysis - By End User
9.1 Overview
9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals and Diagnostic Centers
9.3.1 Overview
9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Academia and Research Institutes
9.4.1 Overview
9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
9.5 Pharmaceutical and Biotechnology Companies
9.5.1 Overview
9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa PCR Technologies Market -Country Analysis
10.1 Middle East & Africa: PCR Technologies Market
10.1.1 Overview
10.1.2 Middle East & Africa PCR Technologies Market Revenue and Forecast and Analysis - By Country
10.1.2.1 Saudi Arabia
10.1.2.1.1 Overview
10.1.2.2 Saudi Arabia PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.1 Saudi Arabia PCR Technologies Market Breakdown by Technology
10.1.2.2.2 Saudi Arabia PCR Technologies Market Breakdown by Offerings
10.1.2.2.2.1 Saudi Arabia PCR Technologies Market Breakdown by Instruments
10.1.2.2.2.2 Saudi Arabia PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.2.2.2.1 Saudi Arabia PCR Technologies Market Breakdown by Vial Size
10.1.2.2.3 Saudi Arabia PCR Technologies Market Breakdown by Application
10.1.2.2.4 Saudi Arabia PCR Technologies Market Breakdown by End User
10.1.2.3 South Africa
10.1.2.3.1 Overview
10.1.2.4 South Africa PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.4.1 South Africa PCR Technologies Market Breakdown by Technology
10.1.2.4.2 South Africa PCR Technologies Market Breakdown by Offerings
10.1.2.4.2.1 South Africa PCR Technologies Market Breakdown by Instruments
10.1.2.4.2.2 South Africa PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.4.2.2.1 South Africa PCR Technologies Market Breakdown by Vial Size
10.1.2.4.3 South Africa PCR Technologies Market Breakdown by Application
10.1.2.4.4 South Africa PCR Technologies Market Breakdown by End User
10.1.2.5 United Arab Emirates
10.1.2.5.1 Overview
10.1.2.6 United Arab
10.1.2.6.1 United Arab Emirates PCR Technologies Market Breakdown by Technology
10.1.2.6.2 United Arab Emirates PCR Technologies Market Breakdown by Offerings
10.1.2.6.2.1 United Arab Emirates PCR Technologies Market Breakdown by Instruments
10.1.2.6.2.2 United Arab Emirates PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.6.2.2.1 United Arab Emirates PCR Technologies Market Breakdown by Vial Size
10.1.2.6.3 United Arab Emirates PCR Technologies Market Breakdown by Application
10.1.2.6.4 United Arab Emirates PCR Technologies Market Breakdown by End User
10.1.2.7 Rest of Middle East & Africa
10.1.2.7.1 Overview
10.1.2.8 Rest of Middle East & Africa PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.8.1 Rest of Middle East & Africa PCR Technologies Market Breakdown by Technology
10.1.2.8.2 Rest of Middle East & Africa PCR Technologies Market Breakdown by Offerings
10.1.2.8.2.1 Rest of Middle East & Africa PCR Technologies Market Breakdown by Instruments
10.1.2.8.2.2 Rest of Middle East & Africa PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.8.2.2.1 Rest of Middle East & Africa PCR Technologies Market Breakdown by Vial Size
10.1.2.8.3 Rest of Middle East & Africa PCR Technologies Market Breakdown by Application
10.1.2.8.4 Rest of Middle East & Africa PCR Technologies Market Breakdown by End User
11. PCR Technologies Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the PCR Technologies Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN NV
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 bioMerieux SA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Hoffmann-La Roche Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bio-Rad Laboratories Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Becton Dickinson and Co
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Takara Bio Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Standard Biotools Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Ellume Ltd
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. PCR Technologies Market Segmentation
Table 2. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Technology
Table 3. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Offerings
Table 4. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
Table 5. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
Table 6. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
Table 7. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Application
Table 8. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By End User
Table 9. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 10. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 11. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 12. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 13. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 14. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 15. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 16. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 17. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 18. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 19. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 20. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 21. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 22. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 23. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 24. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 25. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 26. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 27. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 28. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 29. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 30. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 31. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 32. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 33. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 34. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 35. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 36. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 37. Recent Inorganic Growth Strategies in the PCR Technologies Market
Table 38. Recent Organic Growth Strategies in the PCR Technologies Market
Table 39. Glossary of Terms, PCR Technologies Market
List of Figures
Figure 1. PCR Technologies Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. PCR Technologies Market Revenue (US$ Million), 2020 - 2030
Figure 4. PCR Technologies Market Share (%) - By Technology, 2022 and 2030
Figure 5. Real Time PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Conventional PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Reverse Transcription PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Digital PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Multiplex RT PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 10. Hot Start PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. PCR Technologies Market Share (%) - By Offerings, 2022 and 2030
Figure 13. Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Instruments Market Revenue and Forecasts to 2030 (US$ Million)
Figure 15. Software and Services Market Revenue and Forecasts to 2030 (US$ Million)
Figure 16. PCR Technologies Market Share (%) - By Application, 2022 and 2030
Figure 17. Gene Expression Analysis Market Revenue and Forecasts to 2030 (US$ Million)
Figure 18. Genetic Sequencing Market Revenue and Forecasts to 2030 (US$ Million)
Figure 19. Genotyping Market Revenue and Forecasts to 2030 (US$ Million)
Figure 20. Nucleic Acid Synthesis Market Revenue and Forecasts to 2030 (US$ Million)
Figure 21. Standard Validation Market Revenue and Forecasts to 2030 (US$ Million)
Figure 22. Point of Care Diagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 23. Environmental Application Market Revenue and Forecasts to 2030 (US$ Million)
Figure 24. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 25. PCR Technologies Market Share (%) - By End User, 2022 and 2030
Figure 26. Hospitals and Diagnostic Centers Market Revenue and Forecasts to 2030 (US$ Million)
Figure 27. Academia and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
Figure 28. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
Figure 29. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 30. Middle East & Africa: PCR Technologies Market, by Key Country - Revenue (2022) (US$ Million)
Figure 31. Middle East & Africa PCR Technologies Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 32. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 33. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 34. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 35. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 36. Growth Strategies in the PCR Technologies Market
1. Thermo Fisher Scientific Inc
2. Promega Corp
3. QIAGEN NV
4. bioMerieux SA
5. Hoffmann-La Roche Ltd
6. Bio-Rad Laboratories Inc
7. Becton Dickinson and Co
8. Takara Bio Inc
9. Standard BioTools Inc
10. Ellume Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa PCR technologies market.
- Highlights key business priorities to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa PCR technologies market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.